<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03923855</url>
  </required_header>
  <id_info>
    <org_study_id>899-H1</org_study_id>
    <nct_id>NCT03923855</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the BTL-899 Device for Non-invasive Lipolysis on Human Fat Tissue</brief_title>
  <official_title>Clinical Evaluation of the BTL-899 Device for Non-invasive Lipolysis on Human Fat Tissue</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BTL Industries Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BTL Industries Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The subjects will be enrolled and assigned to a single study group. They will be required to
      complete two treatment visits and come for a biopsy procedure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Actual">October 7, 2019</completion_date>
  <primary_completion_date type="Actual">September 17, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Histology Examination</measure>
    <time_frame>4 months</time_frame>
    <description>Histological examination of the fat tissue after BTL-899 treatment at various days after the procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of Satefy: Occurence of adverse events throughout the study</measure>
    <time_frame>4 months</time_frame>
    <description>Following the occurence of adverse events throughout the study.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Improvement of Abdomen Appearance</condition>
  <arm_group>
    <arm_group_label>BTL-899 Therapy Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BTL-899</intervention_name>
    <description>BTL-899 therapy</description>
    <arm_group_label>BTL-899 Therapy Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age above 21 years and below 60 years

          -  Voluntarily signing of the informed consent form

          -  Women of child-bearing potential are required to use birth control measures during the
             whole duration of the study

          -  Eligibility to fat tissue biopsy at surgeon discretion, incl. at least 3-4 cm
             pinchable fat in the abdominal area

          -  Subjects willing and able to abstain from partaking in any procedure to promote body
             contouring during study participation

          -  Subjects willing and able to maintain his/her regular (pre-procedure) diet and
             exercise regimen without effecting significant change in either direction during study
             participation

        Exclusion Criteria:

          -  Electronic implants (such as cardiac pacemakers, defibrillators and neurostimulators)

          -  Cardiovascular diseases

          -  Disturbance of temperature or pain perception

          -  Pulmonary insufficiency

          -  Metal implants

          -  Drug pumps

          -  Malignant tumor

          -  Hemorrhagic conditions

          -  Septic conditions and empyema

          -  Acute inflammations

          -  Systemic or local infection such as osteomyelitis and tuberculosis

          -  Contagious skin disease

          -  Elevated body temperature

          -  Pregnancy

          -  Breastfeeding

          -  Injured or otherwise impaired muscles

          -  Scars, open lesions and wounds at the treatment area

          -  Basedow's disease

          -  Previous liposuction in the treatment area in the last six months

          -  Abdominal wall diastasis

          -  Unstable weight within the last 6 months (change in weight Â± 3%)

          -  Previous body contouring treatments in the abdomen area in the last three months

          -  Any disease or condition contradicting the fat tissue biopsy at the surgeon discretion

          -  Any disease or condition that may compromise the histologic observation at the
             pathologist discretion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dr. Denkova Dermatology</name>
      <address>
        <city>Sofia</city>
        <zip>1700</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bulgaria</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>April 18, 2019</study_first_submitted>
  <study_first_submitted_qc>April 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2019</study_first_posted>
  <last_update_submitted>December 18, 2019</last_update_submitted>
  <last_update_submitted_qc>December 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

